Found 417 clinical trials
Study Seeking Patients with Schizophrenia
Study Seeking Patients with Schizophrenia
- 0 views
- 07 Nov, 2020
- 6 locations
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia.
schizophrenia on stable antipsychotic treatment.
- 19 views
- 23 Nov, 2020
- 1 location
A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS).
A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS).
- 37 views
- 22 Dec, 2020
- 1 location
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects with Schizophrenia Treated Prospectively for 6-months with Abilify MyCite®
To compare inpatient psychiatric hospitalization rates (proportion of subjects with ≥ 1 inpatient psychiatric hospitalizations) between the retrospective period (Months 1 to 3) while subjects are on oral standard-of-care antipsychotic treatment and the prospective period (Months 1 to 3) after the subjects switch to Abilify MyCite®.
- 26 views
- 23 Nov, 2020
- 1 location
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients with Schizophrenia and Recent Weight Gain While Taking Antipsychotic Medications
To assess the efficacy of miricorilant compared with placebo in reversing recent antipsychoticinduced weight gain (AIWG)
- 47 views
- 23 Nov, 2020
- 1 location
A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 week treatment period in patients with schizophrenia
This study tests whether BI 425809 together with brain training using a computer improves mental functioning in patients with schizophrenia.  
- 51 views
- 23 Nov, 2020
- 1 location
![A multicenter, randomized, double-blind, placebo-controlled, parallel-arm study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of negative symptoms of schizophrenia](/media/imagery/270525.svg)
A multicenter, randomized, double-blind, placebo-controlled, parallel-arm study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of negative symptoms of schizophrenia
The purpose of this research is to evaluate the efficacy, safety and tolerability of AVP-786 compared to placebo for the treatment of negative symptoms of schizophrenia. Negative symptoms of
- 0 views
- 05 Apr, 2021
- 1 location
A Phase 3, Multicenter, Randomized, Double-blind Trial of Fixed-Dose Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Posttraumatic Stress Disorder
of schizophrenia and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder.Otsuka is conducting this study to find out about the potential
- 0 views
- 06 Apr, 2021
- 1 location
Alzheimer’s Disease Research Center (ADRC) Longitudinal Study
This study is looking for people with mild cognitive impairment, young-onset Alzheimer’s, frontotemporal dementia, or Lewy body dementia. The study is also looking for cognitively-normal people over the age of 65, as a comparison. The study will follow the progression of various dementias to help with early detection, accurate diagnosis, …
- 97 views
- 25 May, 2021
- 1 location